Pan K - Search Results

1

Dietary Intervention Favorably Influences Physical Functioning: The Women's Health Initiative Randomized Dietary Modification Trial.

Chlebowski RT, Aragaki AK, Pan K, Nelson RA, Barac A, Manson JE, Stefanick ML, Ikramuddin FS, Johnson KC, Krok-Schoen JL, Laddu D, Pichardo MS, Snetselaar LG, LeBoff MS, Michael Y. Chlebowski RT, et al. Among authors: pan k. J Acad Nutr Diet. 2024 Nov;124(11):1409-1418.e6. doi: 10.1016/j.jand.2024.02.012. Epub 2024 Feb 21. J Acad Nutr Diet. 2024. PMID: 38395355 Clinical Trial.

2

Adjuvant endocrine therapy of perimenopausal and recently postmenopausal women with hormone receptor-positive breast cancer.

Pan K, Chlebowski RT. Pan K, et al. Clin Breast Cancer. 2014 Jun;14(3):147-53. doi: 10.1016/j.clbc.2013.12.010. Epub 2013 Dec 27. Clin Breast Cancer. 2014. PMID: 24503025 Review.

3

Exemestane with ovarian suppression in premenopausal breast cancer.

Chlebowski RT, Pan K. Chlebowski RT, et al. Among authors: pan k. N Engl J Med. 2014 Oct 2;371(14):1358. doi: 10.1056/NEJMc1409366. N Engl J Med. 2014. PMID: 25271612 No abstract available.

4

Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity.

Chlebowski RT, Haque R, Hedlin H, Col N, Paskett E, Manson JE, Kubo JT, Johnson KC, Wactawski-Wende J, Pan K, Anderson G. Chlebowski RT, et al. Among authors: pan k. Breast Cancer Res Treat. 2015 Dec;154(3):609-16. doi: 10.1007/s10549-015-3647-1. Epub 2015 Nov 24. Breast Cancer Res Treat. 2015. PMID: 26602222

5

Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls.

Pan K, Chlebowski RT, Simon MS, Ray RM, Livaudais-Toman J, Sullivan SD, Stefanick ML, Wallace RB, LeBoff M, Bluhm EC, Paskett ED. Pan K, et al. Breast Cancer Res Treat. 2016 Apr;156(3):567-576. doi: 10.1007/s10549-016-3773-4. Epub 2016 Apr 13. Breast Cancer Res Treat. 2016. PMID: 27075917 Free PMC article.

6

Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer.

Chlebowski RT, Pan K, Col NF. Chlebowski RT, et al. Among authors: pan k. Breast Cancer Res Treat. 2017 Jan;161(2):185-190. doi: 10.1007/s10549-016-4024-4. Epub 2016 Oct 26. Breast Cancer Res Treat. 2017. PMID: 27785653 Review.

7

Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome.

Lohmann AE, Goodwin PJ, Chlebowski RT, Pan K, Stambolic V, Dowling RJ. Lohmann AE, et al. Among authors: pan k. J Clin Oncol. 2016 Dec 10;34(35):4249-4255. doi: 10.1200/JCO.2016.69.6187. Epub 2016 Nov 7. J Clin Oncol. 2016. PMID: 27903146 Review.

8

Response.

Chlebowski RT, Pan K, Nananda F. Chlebowski RT, et al. Among authors: pan k. Breast Cancer Res Treat. 2017 Jun;163(3):633-634. doi: 10.1007/s10549-017-4197-5. Epub 2017 Mar 28. Breast Cancer Res Treat. 2017. PMID: 28353060 No abstract available.

9

Emerging combination endocrine therapies for advanced breast cancer.

Pan K, Lin EM, Chlebowski RT. Pan K, et al. Breast J. 2018 Mar;24(2):214-215. doi: 10.1111/tbj.12876. Epub 2017 Jul 26. Breast J. 2018. PMID: 28744960 No abstract available.

10

Complexity of intermittent letrozole adjuvant therapy.

Chlebowski RT, Pan K. Chlebowski RT, et al. Among authors: pan k. Lancet Oncol. 2018 Jan;19(1):13-15. doi: 10.1016/S1470-2045(17)30854-9. Epub 2017 Nov 17. Lancet Oncol. 2018. PMID: 29158010 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,996 results

Search Page

Filters